Annual EPS
$3.66$2.07+130.33%
Summary
- Current Value
- As of today, GSK annual EPS is $3.66, up +130.33% on
- Historical Performance
- GSK annual EPS is down -59.44% over the past 3 years, up +0.03% over the past 5 years
- All-Time High Comparison
- GSK annual EPS is currently -59.44% below its historical high of $9.02 set on
- 3-Year Low Comparison
- GSK annual EPS is +130.33% above its 3-year low of $1.59 reached on
- Sector Comparison
- GSK annual EPS is higher than 93.45% of companies in Healthcare sector
- Upcoming Earnings
- As of today, the next annual earnings release for GSK has not been scheduled
EPS Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EPS | $3.66 | +130.3% | -59.4% | +0.0% | +197.3% | |
| Quarterly EPS | $0.29 | -69.3% | -71.1% | -70.2% | -67.3% | |
| TTM EPS | $3.17 | +48.0% | -64.6% | +8.0% | +26.1% | |
| Price | $50.37 | +29.3% | +43.8% | +19.2% | +18.4% | |
| Annual Revenue | $43.05B | +7.4% | +19.2% | -1.5% | -1.8% | |
| PE Ratio | 15.87 | -12.6% | +305.9% | +10.4% | -6.2% | |
| Annual Net Income | $8.29B | +119.8% | +36.7% | +1.2% | +189.8% | |
| Annual Gross Profit | $30.76B | +9.9% | +28.3% | +3.8% | -3.6% | |
| Shares Outstanding | 2.00B | -1.0% | -1.1% | +0.1% | – |
EPS Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $9.02 | N/A | -59.4% |
| 5Y | $9.02 | -59.4% | |
| All | $9.02 | -59.4% |
EPS Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $1.59 | +130.3% | |
| 5Y | $1.59 | +130.3% | |
| All | $0.63 | +484.8% |
EPS Estimates
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $2.98 | - | |
| - | $1.59 | - | |
| - | $3.66 | - |
🔒 Log In To Unlock Full Data
EPS History
FAQ
- What is the current annual EPS of GSK?
- As of today, GSK annual EPS is $3.66
- What is 1-year change in GSK annual EPS?
- GSK annual EPS is up +130.33% year-over-year
- What is 3-year change in GSK annual EPS?
- GSK annual EPS is down -59.44% over the past 3 years
- How far is GSK annual EPS from its all-time high?
- GSK annual EPS is currently -59.44% below its historical high of $9.02 set on December 31, 2022
- How does GSK annual EPS rank versus sector peers?
- GSK annual EPS is higher than 93.45% of companies in Healthcare sector
- When is GSK next annual earnings release?
- As of today, the next annual earnings release for GSK has not been scheduled
EPS Formula
EPS =
Quarterly EPS
$0.29$0.86-74.98%
Summary
- Current Value
- As of today, GSK quarterly EPS is $0.29, down -74.98% on
- Historical Performance
- GSK quarterly EPS is down -69.33% year-over-year, down -71.06% over the past 3 years
- All-Time High Comparison
- GSK quarterly EPS is currently -95.42% below its historical high of $6.28 set on
- 3-Year Low Comparison
- GSK quarterly EPS is +877.03% above its 3-year low of -$0.04 reached on
- Sector Comparison
- GSK quarterly EPS is higher than 84.68% of companies in Healthcare sector
- Upcoming Earnings
- The next earnings release for GSK is on
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EPS | $0.29 | -75.0% | -69.3% | -71.1% | -70.2% | |
| Annual EPS | $3.66 | – | +130.3% | -59.4% | +0.0% | |
| TTM EPS | $3.17 | -17.0% | +48.0% | -64.6% | +8.0% | |
| Price | $50.37 | +2.8% | +29.3% | +43.8% | +19.2% | |
| Quarterly Revenue | $11.29B | +9.8% | +5.9% | +25.6% | +38.3% | |
| PE Ratio | 15.87 | +23.9% | -12.6% | +305.9% | +10.4% | |
| Quarterly Net Income | $742.26M | -70.0% | -66.2% | -66.0% | -58.2% | |
| Quarterly Gross Profit | $8.47B | +9.7% | +9.0% | +28.7% | +46.1% | |
| Shares Outstanding | 2.00B | – | -1.0% | -1.1% | +0.1% |
Quarterly EPS Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.32 | -78.3% | |
| 3Y | $1.32 | -78.3% | |
| 5Y | $6.23 | -95.4% | |
| All | $6.28 | -95.4% |
Quarterly EPS Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $0.29 | at low | |
| 3Y | -$0.04 | +877.0% | |
| 5Y | -$0.04 | +877.0% | |
| All | -$0.53 | +154.5% |
Quarterly EPS Estimates
| Month | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $1.32 | - | |
| - | $0.41 | - | |
| - | $1.15 | - | |
| - | $0.29 | - |
🔒 Log In To Unlock Full Data
Quarterly EPS History
FAQ
- What is the current quarterly EPS of GSK?
- As of today, GSK quarterly EPS is $0.29
- What is GSK quarterly EPS most recent change?
- GSK quarterly EPS was down -74.98% on June 30, 2026
- What is 1-year change in GSK quarterly EPS?
- GSK quarterly EPS is down -69.33% year-over-year
- How far is GSK quarterly EPS from its all-time high?
- GSK quarterly EPS is currently -95.42% below its historical high of $6.28 set on March 31, 2015
- How does GSK quarterly EPS rank versus sector peers?
- GSK quarterly EPS is higher than 84.68% of companies in Healthcare sector
- When is GSK next earnings release?
- The next earnings release for GSK is on
EPS Formula
EPS =
TTM EPS
$3.17$0.65-17.00%
Summary
- Current Value
- As of today, GSK TTM EPS is $3.17, down -17.00% on
- Historical Performance
- GSK TTM EPS is up +47.95% year-over-year, down -64.59% over the past 3 years
- All-Time High Comparison
- GSK TTM EPS is currently -64.59% below its historical high of $8.96 set on
- 3-Year Low Comparison
- GSK TTM EPS is +106.53% above its 3-year low of $1.54 reached on
- Sector Comparison
- GSK TTM EPS is higher than 91.73% of companies in Healthcare sector
- Upcoming Earnings
- The next earnings release for GSK is on
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EPS | $3.17 | -17.0% | +48.0% | -64.6% | +8.0% | |
| Quarterly EPS | $0.29 | -75.0% | -69.3% | -71.1% | -70.2% | |
| Annual EPS | $3.66 | – | +130.3% | -59.4% | +0.0% | |
| Price | $50.37 | +2.8% | +29.3% | +43.8% | +19.2% | |
| TTM Revenue | $44.55B | +1.4% | +8.8% | +26.3% | +8.4% | |
| PE Ratio | 15.87 | +23.9% | -12.6% | +305.9% | +10.4% | |
| TTM Net Income | $7.08B | -17.1% | +37.3% | +1.3% | +9.4% | |
| TTM Gross Profit | $32.65B | +2.2% | +11.2% | +29.8% | +16.9% | |
| Shares Outstanding | 2.00B | – | -1.0% | -1.1% | +0.1% |
TTM EPS Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $3.82 | -17.0% | |
| 3Y | $8.96 | N/A | -64.6% |
| 5Y | $8.96 | -64.6% | |
| All | $8.96 | -64.6% |
TTM EPS Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $2.15 | N/A | +48.0% |
| 3Y | $1.54 | +106.5% | |
| 5Y | $1.54 | +106.5% | |
| All | $0.00 | N/A |
TTM EPS History
FAQ
- What is the current TTM EPS of GSK?
- As of today, GSK TTM EPS is $3.17
- What is GSK TTM EPS most recent change?
- GSK TTM EPS was down -17.00% on June 30, 2026
- What is 1-year change in GSK TTM EPS?
- GSK TTM EPS is up +47.95% year-over-year
- How far is GSK TTM EPS from its all-time high?
- GSK TTM EPS is currently -64.59% below its historical high of $8.96 set on June 30, 2023
- How does GSK TTM EPS rank versus sector peers?
- GSK TTM EPS is higher than 91.73% of companies in Healthcare sector
- When is GSK next earnings release?
- The next earnings release for GSK is on
EPS Formula
EPS =
Data Sources & References
- GSK Official Website www.gsk.com
- GSK Profile on Yahoo Finance finance.yahoo.com/quote/GSK
- GSK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gsk
